BioRestorative Therapies, Inc. (BRTX)
NASDAQ: BRTX · Real-Time Price · USD
1.550
+0.100 (6.90%)
At close: Dec 20, 2024, 4:00 PM
1.480
-0.070 (-4.52%)
After-hours: Dec 20, 2024, 4:50 PM EST
BioRestorative Therapies Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Revenue | 0.38 | 0.15 | 0.12 | 0.05 | 0.08 | 0.13 | |
| Revenue Growth (YoY) | 189.55% | 21.70% | 160.43% | -40.26% | -40.77% | 17.12% | |
| Cost of Revenue | 0.02 | - | - | - | - | - | |
| Gross Profit | 0.35 | 0.15 | 0.12 | 0.05 | 0.08 | 0.13 | |
| Selling, General & Admin | 7.66 | 11.33 | 15.58 | 25.62 | 1.95 | 6.84 | |
| Research & Development | 4.78 | 4.03 | 3.51 | 0.73 | 0.88 | 1.72 | |
| Operating Expenses | 12.44 | 15.37 | 19.09 | 26.35 | 2.83 | 8.56 | |
| Operating Income | -12.09 | -15.22 | -18.97 | -26.31 | -2.75 | -8.43 | |
| Interest Expense | - | - | - | -1.82 | -1.64 | -5.14 | |
| Interest & Investment Income | 0.87 | 0.55 | 0.01 | - | - | - | |
| Other Non Operating Income (Expenses) | -0.15 | 4.25 | 5.49 | - | -2.14 | 0.82 | |
| EBT Excluding Unusual Items | -11.36 | -10.42 | -13.47 | -28.12 | -6.53 | -12.75 | |
| Other Unusual Items | 1.71 | - | 0.25 | -16.18 | -4.74 | -1.9 | |
| Pretax Income | -9.65 | -10.42 | -13.22 | -44.3 | -11.27 | -14.65 | |
| Net Income | -9.65 | -10.42 | -13.22 | -44.3 | -11.27 | -14.65 | |
| Net Income to Common | -9.65 | -10.42 | -13.22 | -44.3 | -11.27 | -14.65 | |
| Shares Outstanding (Basic) | 7 | 4 | 4 | 1 | 0 | - | |
| Shares Outstanding (Diluted) | 7 | 4 | 4 | 1 | 0 | - | |
| Shares Change (YoY) | 74.26% | 16.60% | 204.60% | 200.92% | - | - | |
| EPS (Basic) | -1.40 | -2.47 | -3.65 | -37.30 | -28.56 | - | |
| EPS (Diluted) | -1.40 | -2.47 | -3.65 | -37.30 | -28.56 | - | |
| Free Cash Flow | -7.63 | -6.6 | -6.18 | -3.36 | -1.96 | -6.95 | |
| Free Cash Flow Per Share | -1.11 | -1.56 | -1.71 | -2.83 | -4.98 | - | |
| Gross Margin | 93.44% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | |
| Operating Margin | -3205.76% | -10439.49% | -15838.08% | -57191.03% | -3574.12% | -6486.16% | |
| Profit Margin | -2558.95% | -7145.20% | -11036.97% | -96311.51% | -14639.85% | -11267.61% | |
| Free Cash Flow Margin | -2025.00% | -4527.61% | -5157.20% | -7305.58% | -2550.99% | -5349.51% | |
| EBITDA | -11.9 | -15.06 | -18.85 | -26.22 | -2.63 | -8.21 | |
| D&A For EBITDA | 0.18 | 0.17 | 0.12 | 0.09 | 0.12 | 0.22 | |
| EBIT | -12.09 | -15.22 | -18.97 | -26.31 | -2.75 | -8.43 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.